News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
186,097 Results
Type
Article (4817)
Company Profile (46)
Press Release (181234)
Section
Business (53405)
Career Advice (291)
Deals (10916)
Drug Delivery (19)
Drug Development (9754)
Employer Resources (28)
FDA (5339)
Job Trends (4530)
News (81738)
Policy (6323)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (3)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
Academia (600)
Allergies (26)
Alliances (18735)
ALS (12)
Alzheimer's disease (269)
Antibody-drug conjugate (ADC) (10)
Approvals (5359)
Artificial intelligence (131)
Autoimmune disease (2)
Automation (14)
Bankruptcy (77)
Best Places to Work (4180)
BIOSECURE Act (3)
Biosimilars (19)
Biotechnology (33)
Bladder cancer (14)
Brain cancer (4)
Breast cancer (51)
Cancer (368)
Cardiovascular disease (21)
Career advice (256)
Career pathing (8)
CAR-T (16)
Cell therapy (74)
Cervical cancer (4)
Clinical research (8105)
Collaboration (335)
Compensation (48)
Complete response letters (2)
COVID-19 (505)
CRISPR (9)
C-suite (53)
Cystic fibrosis (7)
Data (384)
Decentralized trials (2)
Denatured (2)
Depression (9)
Diabetes (43)
Diagnostics (3078)
Digital health (12)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (33)
Drug pricing (14)
Drug shortages (3)
Duchenne muscular dystrophy (2)
Earnings (16966)
Editorial (4)
Employer resources (26)
Events (23708)
Executive appointments (214)
FDA (5694)
Featured Employer (12)
Funding (235)
Gene editing (17)
Generative AI (12)
Gene therapy (54)
GLP-1 (94)
Government (760)
Grass and pollen (1)
Guidances (14)
Healthcare (6083)
Huntington's disease (1)
Immunology and inflammation (7)
Indications (7)
Infectious disease (535)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (12)
Intellectual property (20)
Interviews (38)
IPO (4385)
IRA (3)
Job creations (526)
Job search strategy (210)
Kidney cancer (1)
Labor market (2)
Layoffs (40)
Leadership (4)
Legal (1105)
Liver cancer (6)
Lung cancer (59)
Lymphoma (21)
Machine learning (1)
Management (13)
Manufacturing (117)
MASH (5)
Medical device (6977)
Medtech (6980)
Mergers & acquisitions (6746)
Metabolic disorders (87)
Multiple sclerosis (6)
Neurodegenerative disease (13)
Neuropsychiatric disorders (3)
Neuroscience (350)
NextGen: Class of 2025 (2434)
Non-profit (1045)
Northern California (541)
Now hiring (4)
Obesity (42)
Opinion (37)
Ovarian cancer (10)
Pain (51)
Pancreatic cancer (11)
Parkinson's disease (30)
Partnered (9)
Patents (54)
Patient recruitment (20)
Peanut (16)
People (14172)
Pharmaceutical (9)
Pharmacy benefit managers (3)
Phase I (1906)
Phase II (3125)
Phase III (3476)
Pipeline (170)
Podcasts (2)
Policy (9)
Postmarket research (432)
Preclinical (827)
Press Release (19)
Prostate cancer (18)
Psychedelics (3)
Radiopharmaceuticals (63)
Rare diseases (58)
Real estate (1715)
Recruiting (6)
Regulatory (4890)
Reports (13)
Research institute (627)
Resumes & cover letters (46)
Rett syndrome (1)
RSV (4)
Schizophrenia (6)
Series A (41)
Series B (26)
Service/supplier (8)
Sickle cell disease (7)
Southern California (487)
Sponsored (16)
Startups (819)
State (1)
Supply chain (27)
United States (5768)
Vaccines (101)
Venture capitalists (2)
Webinars (4)
Weight loss (24)
Women's health (13)
Worklife (3)
Date
Today (42)
Last 7 days (204)
Last 30 days (900)
Last 365 days (10283)
2025 (1879)
2024 (10469)
2023 (11595)
2022 (17535)
2021 (18684)
2020 (18857)
2019 (16785)
2018 (12138)
2017 (9525)
2016 (8940)
2015 (9769)
2014 (7114)
2013 (6073)
2012 (6407)
2011 (6230)
2010 (4991)
Location
Africa (148)
Alabama (12)
Alaska (2)
Arizona (52)
Arkansas (3)
Asia (9551)
Australia (1144)
California (1322)
Canada (518)
China (105)
Colorado (93)
Connecticut (66)
Delaware (49)
Europe (25121)
Florida (237)
Georgia (100)
Idaho (41)
Illinois (202)
India (8)
Indiana (174)
Iowa (4)
Japan (41)
Kansas (27)
Kentucky (6)
Louisiana (3)
Maine (26)
Maryland (193)
Massachusetts (806)
Michigan (109)
Minnesota (189)
Mississippi (2)
Missouri (39)
Montana (17)
Nebraska (12)
Nevada (16)
New Hampshire (38)
New Jersey (467)
New Mexico (15)
New York (316)
North Carolina (368)
North Dakota (6)
Northern California (541)
Ohio (78)
Oklahoma (6)
Oregon (12)
Pennsylvania (325)
Puerto Rico (1)
Rhode Island (11)
South America (288)
South Carolina (10)
South Dakota (1)
Southern California (487)
Tennessee (34)
Texas (208)
Utah (49)
Virginia (42)
Washington D.C. (13)
Washington State (95)
West Virginia (2)
Wisconsin (38)
186,097 Results for "analgesic solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
A Novel Non-Opioid Multimodal Analgesic from Xgene Pharmaceutical Reduces Pain and a Need for Opioid Consumption in a Post-Surgical Pain Trial
January 1, 2025
·
5 min read
Pain
Tris Pharma Records Late-Stage Win for Non-Opioid Painkiller
Cebranopadol, a dual-NMR agonist, reached the primary endpoint in a Phase III trial and matched placebo for safety, a significant concern in the analgesic field.
January 22, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Sparian Biosciences Announces Results from the Phase 1 Clinical Trial of First in Class Novel Arylepoxamide Receptor (AEAr) Agonist Analgesic SBS-1000
November 12, 2024
·
3 min read
Pain
Vertex Dips on Mixed Phase II Data for Non-Opioid Pain Therapy
Vertex Pharmaceuticals’ investigational non-opioid analgesic suzetrigine failed to outperform placebo. Investors voiced their concerns as the company’s share price fell 13% in premarket trading.
December 19, 2024
·
2 min read
·
Tristan Manalac
Over-the-counter (OTC) Analgesics Market Size To Surpass USD 40.93 Bn By 2032
The global over-the-counter (OTC) analgesics market size was reached USD 28.6 billion in 2022 and is projected to surpass around USD 40.93 billion by 2032, expanding at a CAGR of 3.7% from 2023 to 2032.
November 9, 2023
·
9 min read
Press Releases
IncreMedical Therapy Solutions Rebrands as Confluent Health System Solutions to Advance Musculoskeletal Rehabilitation Services Nationwide
February 6, 2025
·
3 min read
Policy
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
Elite Pharmaceuticals, Inc. announced that it filed an Abbreviated New Drug Application on August 17, 2023, and was accepted for review by the US Food and Drug Administration on September 19, 2023 for an undisclosed generic drug product in a class of medications called opiate analgesics.
September 25, 2023
·
2 min read
Approvals
Vertex Wins FDA Approval for New Cystic Fibrosis Option but Stock Still Down
The new combination, dubbed Alyftrek, is designed to improve on the Trikafta, a product that generated sales of $8.9 billion in 2023. It’s welcome good news for Vertex following last week’s subpar clinical results for its non-opioid analgesic.
December 23, 2024
·
2 min read
·
Nick Paul Taylor
Press Releases
BioTech Breakthrough Awards BostonGene With “Cancer Immunology Solution of the Year”
February 20, 2025
·
4 min read
Press Releases
Glidewell Launches Glidewell(TM) Tooth Replacement Solution for Implant Treatment
February 21, 2025
·
3 min read
1 of 18,610
Next
